In studies of immune cell defects in autoimmune diabetes mellitus, we observed that complete Freund's adjuvant (CFA) prevented the onset of diabetes when injected into 8- to 10-wk-old prediabetic nonobese diabetic (NOD) mice. The prevalence of the onset of diabetes in the CFA-injected versus uninjected NOD mice was 2 of 81 (2.5%) vs. 231 of 379 (61%) among females and 2 of 44 (4.5%) vs. 83 of 336 (25%) among males, respectively. The incidence of histologically identifiable insulitis was significantly reduced in CFA-treated prediabetic female NOD mice (18%) compared with the incidence in female age-matched controls (70%). Splenocytes or Mac-1+–enriched splenocytes from CFA-treated NOD mice, when cotransferred with splenocytes from diabetic mice, reduced the incidence of diabetes provoked by diabetic splenocytes in vivo. In the spleen, CFA injection induced sustained increases in cell proliferation and an associated major increase in the numbers of an immature cell type that expressed the Mac-1 surface antigen. In CFA-treated NOD mice, lymphocytes derived from the spleen failed to respond in vitro to stimulation by the mitogen concanavalin A or by anti-CD3. When cocultured, Mac-1+ cells, enriched from the splenocytes of CFA-treated mice, suppressed concanavalin A– or anti-CD3–induced proliferation of T lymphocytes derived from either the spleen or thymus of untreated NOD mice. Therefore, treatment with CFA prevents the development of diabetes, and concomitantly, insulitis while stimulating the generation of splenic suppressor cells that are capable of suppressing diabetogenic T-lymphocyte function in vivo and in vitro.
Skip Nav Destination
Article navigation
Original Articles|
June 01 1991
Prevention of Insulitis and Diabetes Onset by Treatment With Complete Freund's Adjuvant in NOD Mice Free
Marcia F McInerney;
Marcia F McInerney
Departments of Microbiology and Immunology and of Internal Medicine (Division of Endocrinology and Metabolism), The University of Michigan
Ann Arbor, Michigan
Search for other works by this author on:
Sumer B Pek;
Sumer B Pek
Departments of Microbiology and Immunology and of Internal Medicine (Division of Endocrinology and Metabolism), The University of Michigan
Ann Arbor, Michigan
Search for other works by this author on:
David W Thomas
David W Thomas
Departments of Microbiology and Immunology and of Internal Medicine (Division of Endocrinology and Metabolism), The University of Michigan
Ann Arbor, Michigan
Search for other works by this author on:
Address correspondence to Sumer Belbez Pek, MD, 5560 Medical Sciences Research Building-2, Box 0678, University of Michigan Medical Center, Ann Arbor, MI 48109.
Diabetes 1991;40(6):715–725
Article history
Received:
May 30 1990
Revision Received:
January 18 1991
Accepted:
January 18 1991
PubMed:
2040388
Citation
Marcia F McInerney, Sumer B Pek, David W Thomas; Prevention of Insulitis and Diabetes Onset by Treatment With Complete Freund's Adjuvant in NOD Mice. Diabetes 1 June 1991; 40 (6): 715–725. https://doi.org/10.2337/diab.40.6.715
Download citation file:
251
Views